PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
1-Year Return
33.7%
This Quarter Return
-6.88%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$216M
AUM Growth
-$123M
(-36%)
Cap. Flow
-$76.5M
Cap. Flow
% of AUM
-35.45%
Top 10 Holdings %
Top 10 Hldgs %
42.5%
Holding
85
New
16
Increased
22
Reduced
28
Closed
18
Top Buys
| 1 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$4.77M |
| 2 |
Schrodinger
SDGR
|
$3.45M |
| 3 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$3.37M |
| 4 |
TECX
Tectonic Therapeutic, Inc. Common Stock
TECX
|
$3.2M |
| 5 |
ITMR
Itamar Medical Ltd. American Depository Shares
ITMR
|
$2.58M |
Top Sells
| 1 |
Zimmer Biomet
ZBH
|
$14.2M |
| 2 |
Boston Scientific
BSX
|
$12.4M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$9.82M |
| 4 |
Tandem Diabetes Care
TNDM
|
$8.05M |
| 5 |
Teleflex
TFX
|
$7M |
Sector Composition
| 1 | Healthcare | 92.89% |
| 2 | Technology | 1.17% |
| 3 | Industrials | 0.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITMR
26
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
| $3.13M | 1.45% |
265,650
+218,750
| +466% | +$2.58M |
|
27
Kodiak Sciences
KOD
$556M
| $3.11M | 1.44% |
65,218
-109,320
| -63% | -$5.21M |
|
28
Vericel Corp
VCEL
$1.72B
| $3.03M | 1.4% |
330,296
-148,204
| -31% | -$1.36M |
|
29
Natera
NTRA
$23.1B
| $2.54M | 1.18% |
85,133
-65,710
| -44% | -$1.96M |
|
|
NUAN
30
DELISTED
Nuance Communications, Inc.
NUAN
| $2.52M | 1.17% |
+150,056
| New | +$2.52M |
|
31
iRadimed
IRMD
$916M
| $2.43M | 1.13% |
113,855
+20,355
| +22% | +$435K |
|
32
Moderna
MRNA
$9.78B
| $2.25M | 1.04% |
+75,000
| New | +$2.25M |
|
33
BridgeBio Pharma
BBIO
$10.2B
| $2.18M | 1.01% |
+75,215
| New | +$2.18M |
|
|
SAGE
34
DELISTED
Sage Therapeutics
SAGE
| $2.15M | 1% |
+75,000
| New | +$2.15M |
|
|
SPNE
35
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
| $2.01M | 0.93% |
245,785
+133,345
| +119% | +$1.09M |
|
36
Madrigal Pharmaceuticals
MDGL
$9.65B
| $2M | 0.93% |
+30,000
| New | +$2M |
|
37
BioCryst Pharmaceuticals
BCRX
$1.74B
| $1.99M | 0.92% |
995,608
-145,604
| -13% | -$291K |
|
38
KALA BIO
KALA
$102M
| $1.98M | 0.92% |
+4,505
| New | +$1.98M |
|
39
Stereotaxis
STXS
$264M
| $1.97M | 0.91% |
653,693
+121,975
| +23% | +$368K |
|
|
XENT
40
DELISTED
Intersect ENT, Inc
XENT
| $1.97M | 0.91% |
165,923
+40,423
| +32% | +$479K |
|
41
Aurinia Pharmaceuticals
AUPH
$1.63B
| $1.75M | 0.81% |
120,288
+20,288
| +20% | +$294K |
|
|
TRIL
42
DELISTED
Trillium Therapeutics Inc.
TRIL
| $1.72M | 0.8% |
+425,000
| New | +$1.72M |
|
43
MeiraGTx Holdings
MGTX
$619M
| $1.68M | 0.78% |
125,000
+42,706
| +52% | +$574K |
|
44
Aclaris Therapeutics
ACRS
$227M
| $1.6M | 0.74% |
1,537,357
+1,312,357
| +583% | +$1.36M |
|
45
Nephros
NEPH
$40.6M
| $1.58M | 0.73% |
251,366
+51,642
| +26% | +$325K |
|
46
Haemonetics
HAE
$2.62B
| $1.51M | 0.7% |
15,147
-45,103
| -75% | -$4.5M |
|
47
InfuSystem Holdings
INFU
$208M
| $1.45M | 0.67% |
170,483
+45,483
| +36% | +$386K |
|
|
MSON
48
DELISTED
Misonix Inc
MSON
| $1.41M | 0.65% |
150,000
-62,500
| -29% | -$589K |
|
49
Alphatec Holdings
ATEC
$2.43B
| $1.3M | 0.6% |
376,599
-73,401
| -16% | -$253K |
|
50
Inspire Medical Systems
INSP
$2.56B
| $1.21M | 0.56% |
20,000
-4,750
| -19% | -$286K |
|